Biologics and biosimilars balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009.Format: [electronic resource] :
Publisher: Washington : U.S. G.P.O.,
Date: 2010. This title can be found in 1 Iowa libraries.
Biologics and biosimilars : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009.Publisher: Washington : U.S. G.P.O. :
Date: 2010. This title can be found in 1 Iowa libraries.
Follow-on biologics hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.Format: [electronic resource] :
Publisher: Washington : U.S. G.P.O.,
Date: 2008. This title can be found in 1 Iowa libraries.
YOU MAY BORROW ITEMS YOU FIND IN THE SILO LOCATOR THROUGH YOUR
LOCAL PUBLIC LIBRARY.
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.